Xponance Inc. Sells 399 Shares of Lam Research Co. (NASDAQ:LRCX)

Xponance Inc. trimmed its position in shares of Lam Research Co. (NASDAQ:LRCX) by 1.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 31,154 shares of the semiconductor company’s stock after selling 399 shares during the period. Xponance Inc.’s holdings in Lam Research were worth $24,402,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Orion Capital Management LLC bought a new position in shares of Lam Research during the third quarter valued at about $25,000. BluePath Capital Management LLC bought a new position in Lam Research in the third quarter worth about $28,000. OFI Invest Asset Management bought a new position in Lam Research in the third quarter worth about $30,000. Asset Dedication LLC raised its stake in Lam Research by 56.7% in the third quarter. Asset Dedication LLC now owns 47 shares of the semiconductor company’s stock worth $30,000 after buying an additional 17 shares in the last quarter. Finally, Valued Wealth Advisors LLC purchased a new stake in Lam Research in the fourth quarter worth about $30,000. 84.61% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

LRCX has been the topic of a number of recent research reports. Stifel Nicolaus upped their price objective on shares of Lam Research from $950.00 to $1,050.00 and gave the stock a “buy” rating in a report on Tuesday. Susquehanna upped their price objective on shares of Lam Research from $655.00 to $880.00 and gave the stock a “neutral” rating in a report on Monday, January 29th. The Goldman Sachs Group upped their price objective on shares of Lam Research from $700.00 to $912.00 and gave the stock a “buy” rating in a report on Thursday, January 25th. UBS Group upped their price objective on shares of Lam Research from $885.00 to $1,130.00 and gave the stock a “buy” rating in a report on Tuesday, March 5th. Finally, Cantor Fitzgerald upped their price objective on shares of Lam Research from $900.00 to $1,100.00 and gave the stock a “neutral” rating in a report on Monday, April 8th. Eight investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Lam Research currently has an average rating of “Moderate Buy” and an average target price of $881.45.

Insider Activity

In other news, SVP Seshasayee Varadarajan sold 5,500 shares of the company’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $922.41, for a total transaction of $5,073,255.00. Following the sale, the senior vice president now directly owns 22,095 shares in the company, valued at approximately $20,380,648.95. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director Abhijit Y. Talwalkar sold 882 shares of the company’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $972.03, for a total transaction of $857,330.46. Following the transaction, the director now directly owns 10,541 shares in the company, valued at approximately $10,246,168.23. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Seshasayee Varadarajan sold 5,500 shares of the company’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $922.41, for a total transaction of $5,073,255.00. Following the transaction, the senior vice president now owns 22,095 shares in the company, valued at $20,380,648.95. The disclosure for this sale can be found here. In the last three months, insiders have sold 7,029 shares of company stock worth $6,559,489. 0.32% of the stock is currently owned by corporate insiders.

Lam Research Price Performance

LRCX stock traded down $23.34 during mid-day trading on Thursday, hitting $888.92. The company had a trading volume of 2,290,234 shares, compared to its average volume of 1,037,548. The company has a market capitalization of $116.54 billion, a price-to-earnings ratio of 35.28, a P/E/G ratio of 3.49 and a beta of 1.51. Lam Research Co. has a 12-month low of $482.74 and a 12-month high of $1,007.39. The company has a quick ratio of 2.02, a current ratio of 3.06 and a debt-to-equity ratio of 0.61. The company has a 50-day moving average price of $945.78 and a 200 day moving average price of $797.54.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings results on Wednesday, January 24th. The semiconductor company reported $7.52 EPS for the quarter, topping the consensus estimate of $7.06 by $0.46. The business had revenue of $3.76 billion for the quarter, compared to analysts’ expectations of $3.71 billion. Lam Research had a net margin of 24.15% and a return on equity of 44.47%. The business’s quarterly revenue was down 28.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $10.71 EPS. On average, research analysts anticipate that Lam Research Co. will post 28.9 earnings per share for the current year.

Lam Research Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, April 3rd. Stockholders of record on Wednesday, March 13th were given a dividend of $2.00 per share. This represents a $8.00 annualized dividend and a dividend yield of 0.90%. The ex-dividend date was Tuesday, March 12th. Lam Research’s dividend payout ratio is 30.94%.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.